Home › Trial NCT01823315
Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia
- Trial IDNCT01823315
- StatusUnknown
- PhasePhase 3
- Study typeInterventional
- SponsorDing Ma
- Enrollment300
- Start date2012-12
- ConditionsGestational Trophoblastic Disease · Gestational Trophoblastic Neoplasia · Gestational Trophoblastic Tumor · Gestational Trophoblastic Neoplasms
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.